Literature DB >> 27433960

Fitness Is Independently Associated with Central Hemodynamics in Metabolic Syndrome.

Joyce S Ramos1, Maximiano V Ramos, Lance C Dalleck, Fabio Borrani, Kaitlyn B Walker, Robert G Fassett, James E Sharman, Jeff S Coombes.   

Abstract

PURPOSE: Fit individuals with metabolic syndrome (MetS) have lower mortality risk compared with less fit counterparts, despite the presence of obesity as a component of the syndrome. To understand the importance of fitness in treating this condition, we examined the association of fitness and fatness with central hemodynamic indices that are known independent predictors of cardiovascular events.
METHODS: Sixty-eight individuals with MetS participated in this cross-sectional study. Central hemodynamics is calculated from radial applanation tonometry and comprised aortic reservoir pressure, backward pressure wave (Pb), reflection magnitude (RM), and augmentation index at 75 bpm (AIx75). Cardiorespiratory fitness (CRF) and body fat percentage (BF%) were determined via indirect calorimetry during maximal exercise testing and dual-energy x-ray absorptiometry, respectively.
RESULTS: CRF was inversely associated with aortic reservoir pressure (r = -0.29, P = 0.02), Pb (r = -0.42, P < 0.001), RM (r = -0.48, P < 0.001), and AIx75 (r = -0.65, P < 0.001). BF% was also correlated with AIx75 (r = 0.37, P < 0.05) and RM (r = 0.36, P < 0.005) but at a weaker association compared with CRF. Multiple regression analysis revealed CRF as a predictor of aortic reservoir pressure (β = -0.52, P = <0.01), Pb (β = -0.41, P < 0.03), and AIx75 (β = -0.45, P = 0.01), independent of BF% and other confounding factors.
CONCLUSIONS: CRF predicts central hemodynamics independent of BF% and other confounding factors. This suggests that CRF improvement may be a higher priority when compared with fat loss for lowering the risk of cardiovascular mortality in MetS individuals.

Entities:  

Mesh:

Year:  2016        PMID: 27433960     DOI: 10.1249/MSS.0000000000000916

Source DB:  PubMed          Journal:  Med Sci Sports Exerc        ISSN: 0195-9131            Impact factor:   5.411


  5 in total

1.  Effects of exercise intensity and cardiorespiratory fitness on the acute response of arterial stiffness to exercise in older adults.

Authors:  Maria Perissiou; Tom G Bailey; Mark Windsor; Michael Chi Yuan Nam; Kim Greaves; Anthony S Leicht; Jonathan Golledge; Christopher D Askew
Journal:  Eur J Appl Physiol       Date:  2018-05-30       Impact factor: 3.078

2.  The effect of different volumes of high-intensity interval training on proinsulin in participants with the metabolic syndrome: a randomised trial.

Authors:  Joyce S Ramos; Lance C Dalleck; Fabio Borrani; Alistair R Mallard; Bronwyn Clark; Shelley E Keating; Robert G Fassett; Jeff S Coombes
Journal:  Diabetologia       Date:  2016-08-01       Impact factor: 10.122

3.  Effect of Different Volumes of Interval Training and Continuous Exercise on Interleukin-22 in Adults with Metabolic Syndrome: A Randomized Trial.

Authors:  Joyce S Ramos; Lance C Dalleck; Rebecca C Stennett; Gregore I Mielke; Shelley E Keating; Lydia Murray; Sumaira Z Hasnain; Robert G Fassett; Michael McGuckin; Ilaria Croci; Jeff S Coombes
Journal:  Diabetes Metab Syndr Obes       Date:  2020-07-09       Impact factor: 3.168

4.  Reservoir-Excess Pressure Parameters Independently Predict Cardiovascular Events in Individuals With Type 2 Diabetes.

Authors:  Kunihiko Aizawa; Francesco Casanova; Phillip E Gates; David M Mawson; Kim M Gooding; W David Strain; Gerd Östling; Jan Nilsson; Faisel Khan; Helen M Colhoun; Carlo Palombo; Kim H Parker; Angela C Shore; Alun D Hughes
Journal:  Hypertension       Date:  2021-06-01       Impact factor: 10.190

5.  Exercise Training Intensity and the Fitness-Fatness Index in Adults with Metabolic Syndrome: A Randomized Trial.

Authors:  Joyce S Ramos; Lance C Dalleck; Mackenzie Fennell; Alex Martini; Talita Welmans; Rebecca Stennett; Shelley E Keating; Robert G Fassett; Jeff S Coombes
Journal:  Sports Med Open       Date:  2021-12-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.